Nerve-induced histamine release is of little importance in psoriatic skin

British Journal of Dermatology

Volumn 139, Issue 3, 1998, Pages 403-409

  Krogstad, A L ^a   Lonnroth P ^a   Larson, G ^a   Wallin, B G ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTAMINE RELEASE; HUMAN; MALE; MAST CELL; PRIORITY JOURNAL; PSORIASIS; SKIN BLOOD FLOW; SKIN NERVE; VASODILATATION; VASOMOTOR REFLEX;

ADULT; ANESTHESIA, LOCAL; EPINEPHRINE; FEMALE; HISTAMINE RELEASE; HUMANS; IONTOPHORESIS; MALE; MICRODIALYSIS; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM; PSORIASIS; REGIONAL BLOOD FLOW; SKIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0031661687     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02402.x     Document Type: Article

References (51)

1. Cox AJ. Mast cells in psoriasis. In: Psoriasis. Proceedings of the Second International Symposium. Stanford University (Cox AJ, Farber EM, eds). New York: Yorke Medical Books, 1976: 36-43.
2. Brody I. Dermal and epidermal involvement in the evolution of the acute eruptive guttate psoriasis vulgaris. J Invest Dermatol 1984; 82: 465-70.
3. Schubert C, Christophers E. Mast cells and macrophages in the early relapsing psoriasis. Arch Dermatol Res 1985; 277: 352-8.
4. Harvima IT, Naukkarinen A, Harvima RJ et al. Quantitative enzyme histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Arch Dermatol Res 1990; 282: 428-33.
5. Toruniowa B, Jablonska S. Mast cell density in the initial stages of psoriatic skin. Arch Dermatol Res 1988; 280: 189-93.
6. Church MK, Lowman MA, Robinson C et al. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol 1989; 88: 70-8.
7. Naukkarinen A, Harvima IT, Paukkonen K et al. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 1993; 285: 341-6.
8. Eedy DJ, Johnston CF, Shaw C, Buchanan KD. Neuropeptides in psoriasis: an immunocytochemical and radio-immunoassay study. J Invest Dermatol 1991; 96: 434-8.
9. Anand P, Springall DR, Blank MA et al. Neuropeptides in skin disease: increased VIP in eczema and psoriasis, but not axillary hyperhidrosis. Br J Dermatol 1991; 124: 547-9.
10. Pincelli C, Fantini F, Romualdi P et al. Substance P is diminished and vasoactive intestinal polypeptide is augmented in psoriatic lesions and these peptides exert disparate effects on the proliferation of cultured human keratinocytes. J Invest Dermatol 1992; 98: 421-7.
11. Krogstad AL, Lönnroth P, Larson G, Wallin BG. Increased interstitial histamine concentration in the psoriatic plaque. J Invest Dermatol 1997; 109: 632-5.
12. Ebertz JM, Hirshman CA, Kettlekamp BC. Substance-P induced histamine release in human cutaneous mast cells. J Invest Dermatol 1987; 88: 682-5.
13. Petersen LJ, Poulsen LK, Söndergaard J, Skov PS. The use of cutaneous microdialysis to measure substance P-induced histamine release in intact human skin in vivo. J Allergy Clin Immunol 1994; 94: 773-83.
14. Wallengren J, Håkanson R. Effects of substance P, neurokinin A and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responses. Eur J Pharmacol 1987; 143: 267-73.
15. Hägermark O, Hökfelt T, Pernow B. Flare and itch induced by substance P in human skin. J Invest Dermatol 1978; 71: 223-35.
16. Jancsó G, Obál F, Tóth-Kása I et al. The modulation of cutaneous inflammatory reactions by peptide-containing sensory nerves. Int J Tissue React 1985; 7: 449-57.
17. Braverman IM. Electron microscopic studies of the microcirculation in psoriasis. J Invest Dermatol 1972; 59: 91-8.
18. 133xenon clearance. J Invest Dermatol 1970; 54: 381-5.
19. Krogstad AL, Swanbeck G, Wallin BG. Axon-reflex-mediated vasodilatation in the psoriatic plaque? J Invest Dermatol 1995; 104: 872-6.
20. Lönnroth P, Strindberg L. Validation of the 'internal reference technique' for calibrating microdialysis in situ. Acta Physiol Scand 1995; 153: 375-80.
21. Anderson C, Andersson T, Andersson RGG. In vivo microdialysis estimation of histamine in human skin. Skin Pharmacol 1992; 5: 177-83.
22. Petersen LJ, Skov PS, Bindslev-Jensen C, Söndergaard J. Histamine release in immediate-type hypersensitivity reactions in intact human skin measured by microdialysis. Allergy 1992; 47: 635-7.
23. Lönnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of the interstitial water space in humans. Am J Physiol 1987; 253: E228-31.
24. Krogstad AL, Jansson PA, Gisslén P, Lönnroth P. The use of cutaneous microdialysis to validate skin metabolism in man. Br J Dermatol 1996; 134: 1005-12.
25. Wårdell K, Jakobsson A, Nilsson GE. Laser Doppler perfusion imaging by dynamic light scattering. IEEE Trans Biomed Eng 1993; 40: 309-16.
26. Jakobsson A, Nilsson GE. Prediction of sampling depth and photon pathlength in laser Doppler flowmetry. Med Biol Eng Comput 1993; 31: 301-7.
27. Sejrsen P. Blood flow in cutaneous tissue in man studied by washout of xenon-133. Circ Res 1969; 25: 215-29.
28. Klemp P, Staberg B. Cutaneous blood flow in psoriasis. J Invest Dermatol 1983; 81: 503-6.
29. Jansson PA, Krogstad AL, Lönnroth P. Microdialysis measurements in skin: evidence for significant lactate release in healthy humans. Am J Physiol 1996; 271: E138-42.
30. Paaske WP. Absence of restricted diffusion in cutaneous capillaries. Acta Physiol Scand 1977; 100: 532-9.
31. Barton SP, Abdullah MS, Marks R. Quantification of microvascular changes in the skin in patients with psoriasis. Br J Dermatol 1992; 126: 569-74.
32. Morel AM, Delaage MA. Immunoanalysis of histamine through a novel chemical derivatization. J Allergy Clin Immunol 1988; 82: 646-54.
33. Braverman IM, Yen A. Microcirculation in psoriatic skin. J Invest Dermatol 1974; 62: 493-502.
34. Braverman IM, Yen A. Ultrastructural study of the capillary loops in the dermal papillae of psoriasis. J Invest Dermatol 1977; 68: 53-60.
35. Juhlin L. Localization and content of histamine in normal and diseased skin. Acta Derm Venereol (Stockh) 1967; 47: 383-91.
36. Naukkarinen A, Harvima IT, Paukkonen K et al. Quantitative analysis of contact sites between mast cells and sensory nerves in cutaneous psoriasis and lichen planus based on a histochemical double staining technique. Arch Dermatol Res 1991; 283: 433-7.
37. Naukkarinen N, Nickoloff BJ, Farber EM. Quantification of cutaneous sensory nerves and their substance P content in psoriasis. J Invest Dermatol 1989; 92: 126-9.
38. Lynn B. Neurogenic inflammation. Skin Pharmacol 1988; 1: 217-24.
39. Gupta MA, Gupta AK, Kirkby S. Pruritus in psoriasis. Arch Dermatol 1988; 124: 1052-7.
40. van Overveld FJ, Jorens PG, Rampart M et al. Tumour necrosis factor stimulates human skin mast cells to release histamine and tryptase. Clin Exp Allergy 1991; 21: 711-14.
41. Subramanian N, Bray MA. Interleukin 1 releases histamine from human basophils and mast cells in vitro. J Immunol 1997; 138: 271-5.
42. Kubota Y. The effect of human anaphylatoxins and neutrophils on histamine release from isolated human skin mast cells. J Dermatol 1992; 19: 19-26.
43. Caughey GH, Leidig F, Viro NF, Nadel JA. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 1988; 244: 133-7.
44. Wårdell K, Naver HK, Nilsson GE, Wallin BG. The cutaneous vascular axon reflex in humans characterized by laser Doppler perfusion imaging. J Physiol (London) 1993; 460: 185-90.
45. Wallengren J, Ekman R, Sundler F. Occurrence and distribution of neuropeptides in the human skin. Acta Derm Venereol (Stockh) 1987; 67: 185-92.
46. Crone C. The permeability of capillaries in various organs determined by the use of the 'indicator diffusion' method. Acta Physiol Scand 1963; 58: 292-305.
47. Moroni F, Fantozzi R, Masini E, Mannaioni PF. The modulation of histamine release by alpha-adrenoceptors: evidences in murine neoplastic mast cells. Agents Actions 1977; 7: 57-61.
48. Kowalski ML, Kaliner MA. Neurogenic inflammation, vascular permeability, and mast cells. J Immunol 1988; 140: 3905-11.
49. 133Xe washout method and laser Doppler velocimetry. J Invest Dermatol 1985; 85: 259-63.
50. Nilsson GE, Tenland T, Öberg PÅ. A new instrument for continuous measurement of tissue blood flow by light beating spectroscopy. IEEE Trans Biomed Eng 1980; 27: 12-19.
51. Petersen LJ, Winge K, Brodin E, Skov PS. No release of histamine and substance P in capsaicin-induced neurogenic inflammation in intact human skin in vivo: a microdialysis study. Clin Exp Allergy 1997; 27: 957-65.